Translate
Sellas Life Sciences Group, Inc.
About
5.22USD-0.03 -0.57%
Closed • Updated at 12:45 GMT+00:00Market Cap$937.42M
Volume5.90M
Beta0.46
RSI56.55
Sellas Life Sciences Group, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 19 2026
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar 17 2026
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Mar 12 2026
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
Jan 14 2026
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
Dec 29 2025
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
Recent Videos
SELLAS Life Sciences surges on earnings beat, trial update By Investing.com
May 12, 2026
SELLAS Life Sciences Group Strategic Financial and Clinical Analysis SLS $SLS #SLS #stockmarket
Apr 27, 2026
SELLAS Explodes 250%! REGAL Phase 3 Data Imminent! SLS Stock Analysis
Apr 27, 2026
SLS Stock to Buy NOW! Phase 3 REGAL About to Explode! SLS Stock Analysis
Apr 20, 2026